| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Do | Adia Med Inc.: Adia Med Delivers Record Q2 Results: $485K Revenue, First Net Profit, and Nearly Matches Full-Year 2025 Revenue in First Half | 352 | Newsfile | Winter Park, Florida--(Newsfile Corp. - August 13, 2026) - Adia Med Inc. (OTCQB: ADIA), a regenerative medicine company focused on stem cell therapies, biologics, and advanced clinical services... ► Artikel lesen | |
| Do | Adia Nutrition, Inc. - 10-Q, Quarterly Report | 5 | SEC Filings | ||
| Di | Adia Med Inc.: Adia Med Partners with Full Sail University; CEO Larry Powalisz to Present Company and Explore Student Assistance with SEO, Social Media, and Marketing | 191 | Newsfile | Winter Park, Florida--(Newsfile Corp. - August 11, 2026) - Adia Med Inc. (OTCQB: ADIA), a regenerative medicine company focused on stem cell therapies and biologics, today announced a new educational... ► Artikel lesen | |
| 05.08. | Adia Med Inc.: Adia Med to Host Dinner for Physicians at Christner's Steakhouse on August 5 to Discuss Clinical Studies and Collaboration Opportunities | 525 | Newsfile | Winter Park, Florida--(Newsfile Corp. - August 5, 2026) - Adia Med Inc. (OTCQB: ADIA), a regenerative medicine company focused on stem cell therapies and biologics, today announced that it will... ► Artikel lesen | |
| 29.07. | Adia Med advances autism study to phase 2, enrolls new cohort | 2 | Investing.com | ||
| 29.07. | Adia Med Inc.: Adia Med Completes Phase 1 and Formally Launches Phase 2 of Autism Spectrum Disorder Clinical Study | 252 | Newsfile | Winter Park, Florida--(Newsfile Corp. - July 29, 2026) - Adia Med Inc. (OTCQB: ADIA) today announced two distinct milestones in its Autism Spectrum Disorder (ASD) clinical research study (ClinicalTrials.gov... ► Artikel lesen | |
| 15.07. | Adia Med Inc.: Adia Med Inc. (Formerly Adia Nutrition Inc.) Launches Redesigned Corporate Website | 523 | Newsfile | Winter Park, Florida--(Newsfile Corp. - July 15, 2026) - Adia Med Inc. (OTCQB: ADIA), a clinical-stage regenerative medicine company, today announced the launch of its redesigned corporate website.... ► Artikel lesen | |
| ADIA MED Aktie jetzt für 0€ handeln | |||||
| 13.07. | Adia Med Inc.: Adia Med's Rise, Highlighting 2.5 Years of Growth Toward NASDAQ | 317 | Newsfile | Winter Park, Florida--(Newsfile Corp. - July 13, 2026) - Adia Med Inc. (OTCQB: ADIA) (formerly Adia Nutrition Inc.), focused on regenerative medicine, stem cell therapies, and biologics, today highlighted... ► Artikel lesen | |
| 09.07. | Adia Med Inc.: Adia Nutrition to Trade as Adia Med Inc. After Lightning-Fast FINRA Review | 223 | Newsfile | Winter Park, Florida--(Newsfile Corp. - July 9, 2026) - Adia Nutrition, Inc. (OTCQB: ADIA) announced today that FINRA has processed its corporate name change to Adia Med Inc. on an expedited timeline.... ► Artikel lesen | |
| 07.07. | Adia Nutrition nears final approval for name change to Adia Med | 1 | Investing.com | ||
| 07.07. | Adia Nutrition Inc.: Adia Nutrition Inc. Enters FINRA Home Stretch for Corporate Name Change to Adia Med Inc. | 474 | Newsfile | Winter Park, Florida--(Newsfile Corp. - July 7, 2026) - Adia Nutrition Inc. (OTCQB: ADIA) today announced it has entered the final stage of its corporate name change application from Adia Nutrition... ► Artikel lesen | |
| 30.06. | Adia Nutrition Inc.: Adia Med Finds Another Unicorn | 385 | Newsfile | Winter Park, Florida--(Newsfile Corp. - June 30, 2026) - Adia Med Inc. (OTCQB: ADIA), a regenerative medicine and stem cell therapies company, today announced that CEO Larry Powalisz recently sat... ► Artikel lesen | |
| 16.06. | Adia Nutrition Inc.: Adia Med Improves Quality of Care with Advanced Ultrasound-Guided IV Training | 366 | Newsfile | Winter Park, Florida--(Newsfile Corp. - June 16, 2026) - Adia Med, the regenerative medicine and advanced IV therapy division of Adia Nutrition Inc. (OTCQB: ADIA), today announced a major step forward... ► Artikel lesen | |
| 10.06. | Adia Nutrition Inc.: Adia Nutrition Inc. Delivers Exciting Update: Name Change to Adia Med Inc. Now Official in Nevada | 377 | Newsfile | Winter Park, Florida--(Newsfile Corp. - June 10, 2026) - Adia Nutrition Inc. (OTCQB: ADIA) is pleased to confirm that the State of Nevada has officially approved the company's name change to Adia... ► Artikel lesen | |
| 08.06. | Adia Nutrition Inc.: Adia Nutrition Launches Dynamic New Subsidiary ADIA Life LLC in Florida to Supercharge Distribution and Unlock a Full Spectrum of Life-Transforming Wellness Solutions | 483 | Newsfile | Winter Park, Florida--(Newsfile Corp. - June 8, 2026) - Adia Nutrition (OTCQB: ADIA), a leader in advanced nutrition and regenerative health products, today announced the official launch of its... ► Artikel lesen | |
| 02.06. | Adia Nutrition Inc.: Adia Nutrition, Inc. Drops Explosive Sneak Peek of Upcoming Documentary Featuring TNA Wrestling Star Jeff Sciullo (Elias) | 424 | Newsfile | Winter Park, Florida--(Newsfile Corp. - June 2, 2026) - Adia Nutrition, Inc. (OTCQB: ADIA) is thrilled to announce that the powerful new documentary showcasing TNA Wrestling star and former WWE... ► Artikel lesen | |
| 26.05. | Adia Nutrition Inc.: Adia Nutrition Announces Expanded Stem Cell Coverage Through Independent Monthly-Membership Health Care Sharing Ministry | 279 | Newsfile | Winter Park, Florida--(Newsfile Corp. - May 26, 2026) - Adia Nutrition Inc. (OTCQB: ADIA), a publicly traded company advancing regenerative medicine and innovative healthcare solutions, today announced... ► Artikel lesen | |
| 15.05. | Adia Nutrition Inc.: ADIA Nutrition, Inc. Reports Strong Revenue Growth and Operational Momentum for First Quarter 2026 | 326 | Newsfile | Winter Park, Florida--(Newsfile Corp. - May 15, 2026) - ADIA Nutrition, Inc. (OTCQB: ADIA), a leader in advanced nutrition and regenerative health solutions, today announced its 3rd party reviewed... ► Artikel lesen | |
| 15.05. | Adia Nutrition, Inc. - 10-Q, Quarterly Report | 2 | SEC Filings | ||
| 11.05. | ADIA Nutrition erhält IRB-Zulassung für vier klinische Studien | 3 | Investing.com Deutsch |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS | 47,660 | 0,00 % | ANALYSE-FLASH: JPMorgan senkt Ziel für Fresenius auf 55,20 Euro - 'Overweight' | NEW YORK (dpa-AFX) - Die US-Bank JPMorgan hat das Kursziel für Fresenius von 56,60 auf 55,20 Euro gesenkt, aber die Einstufung auf "Overweight" belassen. David Adlington lobte am Mittwoch in seinem... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 40,990 | -0,05 % | BARCLAYS stuft FMC FRESENIUS MEDICAL CARE AG auf 'Equal Weight' | LONDON (dpa-AFX Analyser) - Die britische Investmentbank Barclays hat das Kursziel für FMC von 46,00 auf 44,50 Euro gesenkt, aber die Einstufung auf "Equal Weight" belassen. Zu den Behandlungszahlen... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 39,040 | +0,03 % | Siemens macht Fortschritte bei Abspaltung von Healthineers | MÜNCHEN (dpa-AFX) - Der Technologiekonzern Siemens kommt bei der geplanten Abspaltung seiner Medizintechniktochter Siemens Healthineers voran. So seien die relevanten steuerlichen Themen mit den Finanzbehörden... ► Artikel lesen | |
| AVEANNA HEALTHCARE | 11,275 | +24,59 % | Aveanna Healthcare: Aktie steigt nach übertroffenen Umsatzerwartungen und erhöhter Jahresprognose | ||
| CARL ZEISS MEDITEC | 30,440 | +2,08 % | Ihre wichtigsten Termine: Alle Analysten-Augen auf: Rheinmetall, Deutsche Telekom, Siemens, Airbnb & Lyft | © Foto: Julian Stratenschulte/dpa Gut geplant in den Tag. Mit dem wO-Tagesausblick haben Sie die wichtigsten Termine im Blick und starten bestens vorbereitet in den neuen Handelstag.Untermehmenstermine... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 60,21 | -0,03 % | BrightSpring Health Services, Inc. Reports Second Quarter 2026 Financial Results and Increases Full Year 2026 Guidance | LOUISVILLE, Ky., July 31, 2026 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ: BTSG), a leading provider of home and community-based health services... ► Artikel lesen | |
| HEARTFLOW | 31,070 | +4,09 % | Heartflow, Inc.: Heartflow Reports First Quarter 2026 Financial Results and Raises Full Year 2026 Guidance | SAN FRANCISCO, May 14, 2026 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), the leader in AI technology for coronary artery disease (CAD), today reported financial results for the... ► Artikel lesen | |
| LIFESTANCE HEALTH GROUP | 12,225 | -0,04 % | LifeStance Health Group, Inc.: LifeStance Reports Strong Second Quarter 2026 Financial Results and Raises Full Year Outlook | SCOTTSDALE, Ariz., Aug. 06, 2026 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 13,455 | 0,00 % | Can ALHC's Raised 2026 Outlook Offset Heavier Second-Half Spending? | ||
| BILLIONTOONE | 94,00 | -3,54 % | Diagnostiksektor: BTIG kürt BillionToOne zum Top-Pick | ||
| ECKERT & ZIEGLER | 13,650 | -0,73 % | EQS-News: Eckert & Ziegler SE: Eckert & Ziegler im ersten Halbjahr 2026 auf Kurs | EQS-News: Eckert & Ziegler SE
/ Schlagwort(e): Quartals-/Zwischenmitteilung/Quartalsergebnis
Eckert & Ziegler im ersten Halbjahr 2026 auf Kurs
13.08.2026 / 07:45 CET/CEST
Für... ► Artikel lesen | |
| GENEDX | 79,13 | -3,96 % | GeneDx launches online exome testing for pediatric patients | ||
| SANARA MEDTECH | 34,160 | 0,00 % | Sanara MedTech Inc. Reports Second Quarter 2026 Financial Results (Unaudited) | FORT WORTH, TX, Aug. 11, 2026 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. ("Sanara," "Sanara MedTech," the "Company," "we," "our" or "us") (Nasdaq: SMTI), a medical technology company focused on developing... ► Artikel lesen | |
| PROGYNY | 25,880 | 0,00 % | Progyny, Inc. Announces Second Quarter 2026 Results | Reports Record Quarterly Revenue, Gross Profit and Adjusted EBITDARobust Selling Season Activity Continues to Reflect Strong Demand for Women's Health, Family Building SolutionsValue Returned to Shareholders... ► Artikel lesen | |
| BETA BIONICS | 18,070 | +4,27 % | Beta Bionics, Inc.: Beta Bionics Announces Second Quarter 2026 Financial Results and Updates Full Year 2026 Guidance | IRVINE, Calif., July 29, 2026 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its financial... ► Artikel lesen |